RDSNF (Redsense Medical AB) ROCE %: 12.43% (As of Mar. 2026)

What is Redsense Medical AB ROCE %?

Redsense Medical AB RDSNF -51.43% 54 ROCE % is 12.43% as of Mar. 2026. GuruFocus rates RDSNF with a GF Score™ of 54/100 and a GF Value™ of $0.77. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Redsense Medical AB's annualized ROCE % for the quarter that ended in Mar. 2026 was 12.43%.

Redsense Medical AB (OTCPK:RDSNF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Redsense Medical AB ROCE % Related Terms

Redsense Medical AB ROCE % Historical Data

* Premium members only.

The historical data trend for Redsense Medical AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redsense Medical AB ROCE % Chart

Redsense Medical AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-13.24

-23.75

-17.95

1.16

-21.06

Redsense Medical AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-34.08	-20.53	-4.83	-22.33	12.43

54GF Score

Redsense Medical AB RDSNF

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Redsense Medical AB ROCE % Calculation

Redsense Medical AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-0.768	/	( ( (3.805 - 0.201)	+	(4.224 - 0.535) )	/ 2 )
	=	-0.768	/	( (3.604	+	3.689)	/ 2 )
	=	-0.768	/	3.6465
	=	-21.06 %

Redsense Medical AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	0.464	/	( ( (4.224 - 0.535)	+	(4.249 - 0.47) )	/ 2 )
	=	0.464	/	( ( 3.689	+	3.779 )	/ 2 )
	=	0.464	/	3.734
	=	12.43 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 12.43% mean?

Redsense Medical AB (RDSNF) has a ROCE % of 12.43% as of Mar. 2026.

Is Redsense Medical AB's ROCE % too high?

Redsense Medical AB's current ROCE % is 12.43%. The Medical Devices & Instruments industry median ROCE % is 2.23. Redsense Medical AB's value of 12.43% is 457.4% above this industry median. Overall, Redsense Medical AB has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.

How does Redsense Medical AB's ROCE % compare to ABT and SYK?

Redsense Medical AB's ROCE % of 12.43% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Redsense Medical AB's value of 12.43% is 457.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redsense Medical AB's current ROCE % of 12.43% is 457.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redsense Medical AB's current ROCE % is 12.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Redsense Medical AB stock overvalued right now?

Redsense Medical AB (RDSNF) has a current ROCE % of 12.43%. The stock's GF Value™ is $0.77, compared to a current price of $0.51 — trading 33.8% below its estimated fair value. The current ROCE % is 12.43% and 457.4% above the Medical Devices & Instruments industry median of 2.23. Redsense Medical AB's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Redsense Medical AB (RDSNF), the current ROCE % is 12.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redsense Medical AB (RDSNF) Overvalued in 2026?

Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued. The current stock price of $0.51 is trading 33.8% below its estimated GF Value™ of $0.77.

Key valuation signals for RDSNF:

ROCE %: 12.43%
GF Value™: $0.77 vs. price of $0.51 (33.8% below fair value)
GF Score™: 54/100 with 5 warning signs
Industry Position: 457.4% above the Medical Devices & Instruments median

No single metric tells the full story. See the RDSNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redsense Medical AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSTO:QLIFE OSTO:SDOS XSAT:BIBB OSTO:SPEC OSTO:NEOLA XSAT:POLAR XSAT:VSD B OSTO:PERP B XSAT:PEXA B XSAT:ZENI ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges REDS:Sweden

Address Storgatan 36, Halmstad, SWE, 302 43

Website https://www.redsensemedical.com

Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.

54GF Score

Get the complete analysis for RDSNF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51

Price

$0.77

GF Value

View RDSNF Analysis

See ROCE % data for all stocks →